Sigmoid Pharma / Sublimity Therapeutics2021-05-06T11:08:02+01:00
Sigmoid’s goal is to identify and create meaningful new therapies for unmet clinical needs in gastrointestinal and immunological diseases and disorders. The company has recently been renamed as Sublimity Therapeutics.